Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line

Cancer Investigation

Volumn 28, Issue 10, 2010, Pages 1019-1023

  Song, Xiangfeng ^a   Tian, Zhongwei ^a   Wang, Shuxing ^b   Peng, Zhenhui ^c   Feng, Jie ^c  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Gene therapy; Human cutaneous T cell lymphoma; Tumor suppressor gene

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; LIPOSOME;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ACID ANHYDRIDE HYDROLASES; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TRANSFECTION;

EID: 78649249090     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902849608     Document Type: Article

References (20)

1. Iliopoulos, D.; Guler, G.; Han, S. Y.; Druck, T.; Ottey, M.; McCorkell, K. A.; Huebner, K. Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett 2006, 232 (1), 27-36.
2. Song, L.; Yan, W.; Deng, M.; Song, S.; Zhang, J.; Zhao, T. Aberrations in the fragile histidine triad (FHIT) gene may be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis. Tumour Biol 2004, 25 (5-6), 270-275.
3. Kujan, O.; Oliver, R.; Roz, L.; Sozzi, G.; Ribeiro, N.; Woodwards, R.; Thakker, N.; Sloan, P. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions. Clin Cancer Res 2006, 12 (22), 6723-6729.
4. Ceçener, G.; Egeli, U.; Tunca, B.; Taşdelen, I.; Tolunay, S.; Bilgel, N. Importance of novel sequence alterations in the FHIT gene on formation of breast cancer. Tumori 2007, 93, 597-603.
5. Mimori, K.; Inoue, H.; Shiraishi, T.; Matsuyama, A.; Mafune, K.; Tanaka, Y.; Mori, M. Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus. Oncology 2003, 64 (3), 275-279.
6. Rocco, A.; Schandl, L.; Chen, J.; Wang, H.; Tulassay, Z.; McNamara, D.; Malfertheiner, P.; Ebert, M. P. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol 2003, 129, 84-88.
7. Sard, L.; Accornero, P.; Tornielli, S.; Delia, D.; Bunone, G.; Campiglio, M.; Colombo, M. P.; Gramegna, M.; Croce, C. M.; Pierotti, M. A.; Sozzi, G. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 1999, 96 (15), 8489-8492.
8. Werner, N. S.; Siprashvili, Z.; Fong, L. Y.; Marquitan, G.; Schröder, J. K.; Bardenheuer, W.; Seeber, S.; Huebner, K.; Schütte, J.; Opalka, B. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous FHIT expression. Cancer Res 2000, 60 (11), 2780-2785.
9. Pichiorri, F.; Trapasso, F.; Palumbo, T.; Aqeilan, R. I.; Drusco, A.; Blaser, B. W.; Iliopoulos, D.; Caligiuri, M. A.; Huebner, K.; Croce, C. M. Preclinical assessment of FHIT gene-replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Clin Cancer Res 2006, 12 (11), 3494-3501.
10. Sevignani, C.; Calin, G. A.; Cesari, R.; Sarti, M.; Ishii, H.; Yendamuri, S.; Vecchione, A.; Trapasso, F.; Croce, C. M. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 2003, 63 (6), 1183-1187.
11. Tian, Z. W.; Song, X. F.; Peng, Z. H. The study of the loss of FHIT gene in cutaneous T cell lymphomas Hut-78 cell. Chin J Derm Venereol 2003, 17 (5), 289-290.
12. Tian, Z. W.; Feng, J.; Song, X. F.; Ma, H. Q.; Peng, Z. H. Detection of fragile histidine triad protein in cutis squamous cell carcinoma and its clinical significance. Chin J Derm Venereol 2005, 19 (2), 68-70.
13. Tian, Z. W.; Feng, J.; Song, X. F.; Peng, Z. H. Construction of eukaryotic expression plasmid pcDNA3-FHIT and its transient expression in COS-1 cells. J Nanjing Med Univ (JNMU) 2004, 18 (5), 275-277.
14. Ohta, M.; Inoue, H.; Cotticelli, M. G.; Kastury, K.; Baffa, R.; Palazzo, J.; Siprashvili, Z.; Mori, M.; McCue, P.; Druck, T.; Croce, C. M.; Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t (3;8) breakpoint, is abnormal in digestive tract cancer. Cell 1996, 84 (3), 587-597.
15. Tutar, E.; Kiyici, H. Role of fragile histidine triad protein expression in pathogenesis of malignant pleural mesothelioma. Pathology 2008, 40 (1), 42-45.
16. Zucchini, C.; Concu, M.; Martini, F.; Morelli, C.; Salfi, N.; Carinci, P.; Tognon, M.; Caramelli, E. FHIT oncosuppressor gene expression profile in human anal cancers. Int J Biol Markers 2007, 22, 39-42.
17. Ishii, H.; Zanesi, N.; Vecchione, A.; Trapasso, F.; Yendamuri, S.; Sarti, M.; Baffa, R.; During, M. J.; Huebner, K.; Fong, L. Y.; Croce, C. M.; et al. Prevention and regression of upper gastric cancer in mice by FHIT gene therapy. FASEB J 2003, 17, 1768-1770.
18. Kim, C. H.; Yoo, J. S.; Lee, C. T.; Kim, Y. W.; Han, S. K.; Shim, Y. S.; Yoo, C. G. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells. Int J Cancer 2006, 118, 1692-1698.
19. Simoes, S.; Pires, P.; Duzgunes, N.; Pedrosa de Lima, M. C. Cationic liposomes as gene transfer vectors: barriers to successful application in gene therapy. Curr Opin Mol 1999, 1 (2), 147-157.
20. Ito, K.; Chen, J.; Asano, T.; Vaughan, E. D. Jr.; Poppas D. P.; Hayakawa M.; Felsen D. Liposome-mediated gene therapy in the kidney. Hum Cell 2004, 17, 17-28.